Ziopharm Oncology (ZIOP) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ziopharm Oncology (ZIOP) Reports In-Line Q2 EPS

Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update

August 6, 2020 4:04 PM EDT

Enrollment completed in Controlled IL-12 phase 2 clinical trial with Regenerons Libtayo® First patient with DIPG dosed in phase 1/2 pediatric brain tumor trial of Contolled IL-12 Work restrictions at the NCI and MD Anderson easing; MD Anderson initiated phase 1 CD19-specific CAR-T clinical trial using RPM Eden BioCell on track for Taiwan IND filing for autologus CAR-T clinical trial this year

Company to host conference call and webcast today, August 6, at 4:30 p.m. EDT

BOSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) --... More